128 related articles for article (PubMed ID: 25943116)
1. Estrogen-Induced Cholestasis Leads to Repressed CYP2D6 Expression in CYP2D6-Humanized Mice.
Pan X; Jeong H
Mol Pharmacol; 2015 Jul; 88(1):106-12. PubMed ID: 25943116
[TBL] [Abstract][Full Text] [Related]
2. Cholic Acid Feeding Leads to Increased CYP2D6 Expression in CYP2D6-Humanized Mice.
Pan X; Kent R; Won KJ; Jeong H
Drug Metab Dispos; 2017 Apr; 45(4):346-352. PubMed ID: 28153841
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of small heterodimer partner governs cytochrome P450 (CYP) 2D6 induction during pregnancy in CYP2D6-humanized mice.
Koh KH; Pan X; Shen HW; Arnold SL; Yu AM; Gonzalez FJ; Isoherranen N; Jeong H
J Biol Chem; 2014 Feb; 289(6):3105-13. PubMed ID: 24318876
[TBL] [Abstract][Full Text] [Related]
4. Farnesoid X Receptor Agonist Represses Cytochrome P450 2D6 Expression by Upregulating Small Heterodimer Partner.
Pan X; Lee YK; Jeong H
Drug Metab Dispos; 2015 Jul; 43(7):1002-7. PubMed ID: 25926433
[TBL] [Abstract][Full Text] [Related]
5. Effects of Fenofibrate on the Expression of Small Heterodimer Partner (SHP) and Cytochrome P450 (CYP) 2D6.
Kent R; Jeong H
Drug Metab Lett; 2017 Nov; 11(1):68-72. PubMed ID: 28403802
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte nuclear factor (HNF) 4α transactivation of cytochrome P450 (Cyp) 2d40 promoter is enhanced during pregnancy in mice.
Ning M; Koh KH; Pan X; Jeong H
Biochem Pharmacol; 2015 Mar; 94(1):46-52. PubMed ID: 25598084
[TBL] [Abstract][Full Text] [Related]
7. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor alpha regulates expression of the orphan receptor small heterodimer partner.
Lai K; Harnish DC; Evans MJ
J Biol Chem; 2003 Sep; 278(38):36418-29. PubMed ID: 12842887
[TBL] [Abstract][Full Text] [Related]
9. Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine.
He ZX; Chen XW; Zhou ZW; Zhou SF
Drug Metab Rev; 2015; 47(4):470-519. PubMed ID: 26574146
[TBL] [Abstract][Full Text] [Related]
10. Estrogen and Estrogen Receptor-α-Mediated Transrepression of Bile Salt Export Pump.
Chen Y; Vasilenko A; Song X; Valanejad L; Verma R; You S; Yan B; Shiffka S; Hargreaves L; Nadolny C; Deng R
Mol Endocrinol; 2015 Apr; 29(4):613-26. PubMed ID: 25675114
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity.
Yamamoto Y; Moore R; Hess HA; Guo GL; Gonzalez FJ; Korach KS; Maronpot RR; Negishi M
J Biol Chem; 2006 Jun; 281(24):16625-31. PubMed ID: 16606610
[TBL] [Abstract][Full Text] [Related]
12. Yangonin protects against estrogen-induced cholestasis in a farnesoid X receptor-dependent manner.
Dong R; Wang J; Gao X; Wang C; Liu K; Wu J; Liu Z; Sun H; Ma X; Meng Q
Eur J Pharmacol; 2019 Aug; 857():172461. PubMed ID: 31220436
[TBL] [Abstract][Full Text] [Related]
13. Cholestasis-induced bile acid elevates estrogen level via farnesoid X receptor-mediated suppression of the estrogen sulfotransferase SULT1E1.
Liu X; Xue R; Yang C; Gu J; Chen S; Zhang S
J Biol Chem; 2018 Aug; 293(33):12759-12769. PubMed ID: 29929982
[TBL] [Abstract][Full Text] [Related]
14. Role of AMP-activated protein kinase α1 in 17α-ethinylestradiol-induced cholestasis in rats.
Li X; Liu R; Luo L; Yu L; Chen X; Sun L; Wang T; Hylemon PB; Zhou H; Jiang Z; Zhang L
Arch Toxicol; 2017 Jan; 91(1):481-494. PubMed ID: 27090119
[TBL] [Abstract][Full Text] [Related]
15. Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function.
Milona A; Owen BM; Cobbold JF; Willemsen EC; Cox IJ; Boudjelal M; Cairns W; Schoonjans K; Taylor-Robinson SD; Klomp LW; Parker MG; White R; van Mil SW; Williamson C
Hepatology; 2010 Oct; 52(4):1341-9. PubMed ID: 20842631
[TBL] [Abstract][Full Text] [Related]
16. High-Fat Diet Feeding Alters Expression of Hepatic Drug-Metabolizing Enzymes in Mice.
Ning M; Jeong H
Drug Metab Dispos; 2017 Jul; 45(7):707-711. PubMed ID: 28442500
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
[TBL] [Abstract][Full Text] [Related]
18. Krüppel-like factor 9 promotes hepatic cytochrome P450 2D6 expression during pregnancy in CYP2D6-humanized mice.
Koh KH; Pan X; Zhang W; McLachlan A; Urrutia R; Jeong H
Mol Pharmacol; 2014 Dec; 86(6):727-35. PubMed ID: 25217496
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis.
Fiorucci S; Clerici C; Antonelli E; Orlandi S; Goodwin B; Sadeghpour BM; Sabatino G; Russo G; Castellani D; Willson TM; Pruzanski M; Pellicciari R; Morelli A
J Pharmacol Exp Ther; 2005 May; 313(2):604-12. PubMed ID: 15644430
[TBL] [Abstract][Full Text] [Related]
20. Hepatic estrogen receptor α improves hepatosteatosis through upregulation of small heterodimer partner.
Wang X; Lu Y; Wang E; Zhang Z; Xiong X; Zhang H; Lu J; Zheng S; Yang J; Xia X; Yang S; Li X
J Hepatol; 2015 Jul; 63(1):183-90. PubMed ID: 25720568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
